Live Breaking News & Updates on Adenocarcinoma

Stay informed with the latest breaking news from Adenocarcinoma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Adenocarcinoma and stay connected to the pulse of your community

Add-On Fruquintinib Delays Progression in Gastric Cancer

Fruquintinib plus paclitaxel improves cancer progression-free, but not overall survival, in patients with gastric/gastroesophageal cancer who have progressed on frontline chemotherapy.

China , Guangzhou , Guangdong , Rui-hua-xu , Sun-yat-sen-university-cancer-center , Noncolorectal-gastrointestinal-cancer , Oncolorectal-gi-cancer , Cancer , Alignant-neoplasia , Arcinoma , Alignant-neoplasm

Treatment Sequence May Impact Pancreatic Cancer Survival

The sequence of systemic therapies for advanced pancreatic ductal adenocarcinoma can affect overall patient survival, a new analysis suggests.

China , Beijing , Chinese , Guanghai-dai , Chinese-people-liberation-army , Chinese-people , Liberation-army-general-hospital , Malignant-pancreatic-neoplasm , Ancreatic-cancer , Ancer-of-the-pancreas , Adenocarcinoma , Cancer

US FDA Declines to Approve Astellas' Gastric Cancer Drug

Japan's Astellas Pharma said on Monday the U.S. Food and Drug Administration (FDA) has declined to approve its experimental drug to treat a type of gastric cancer, citing...

Japan , Bengaluru , Karnataka , India , Astellas-pharma , Drug-administration , Reuters , Mariam-sunny , Rashmi-aich , Noncolorectal-gastrointestinal-cancer , Oncolorectal-gi-cancer , Gastric-cancer

Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression

Study demonstrates that inhibiting stromal class I histone deacetylases (HDACs) can effectively slow down pancreatic cancer progression, shedding light on a new therapeutic approach targeting the tumor microenvironment.

Tattoboo-shutterstock , Nature-communications , Adenocarcinoma , Ancer , Ell , Hromatin , Ibroblast , Enes , N-vitro , N-vivo , Ancreas , Ancreatic-cancer

Long-Term Organ Preservation in Rectal Cancer Is Possible

Long-term data from the OPRA trial show organ preservation at 5 years in about half of patients with stage II/III rectal adenocarcinoma who received total neoadjuvant therapy.

Memorial-sloan-kettering-cancer-center , New-york , United-states , Floriss-verheij , New-york-city , Colorectal-cancer , Malignant-rectal-neoplasm , Ectal-cancer , Ancer-rectal- , Cancer , Alignant-neoplasia